Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Nuclear Imaging Equipment Pipeline Market Report Overview

Nuclear Imaging Equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.

The nuclear imaging equipment pipeline market research report provides comprehensive information about the nuclear imaging equipment pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Positron Emission Tomography (PET) Systems

·        Positron Emission Tomography/Computed Tomography (PET/CT) Systems

·        Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems

·        Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems

·        Single Photon Emission Computed Tomography (SPECT) Systems

·        Gamma Camera

Key Territories ·        The US

·        Europe

·        Canada

·        China

·        Israel

·        Russia

Key Regulatory Paths ·        510(k)

·        CE

·        MDL

·        NMPA

Leading Companies ·        Brain Biosciences Inc

·        Canon Medical Systems USA Inc

·        Cubresa Inc

·        EXINI Diagnostics AB

·        FMI Medical Systems Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Nuclear Imaging Equipment Pipeline Market by Segments

Some of the key segments in the nuclear imaging equipment pipeline market are Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems, Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems, Single Photon Emission Computed Tomography (SPECT) Systems, and Gamma Camera, among others. As of November 2023, Positron Emission Tomography (PET) Systems have the highest number of pipeline products.

Nuclear Imaging Equipment Pipeline Market Analysis by Segments, 2023 (%)

Nuclear Imaging Equipment Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Nuclear Imaging Equipment Pipeline Market

Download a Free Report Sample

Nuclear Imaging Equipment Pipeline Market Segmentation by Territories

Some of the key territories in the nuclear imaging equipment market are the US, Europe, Canada, China, Israel, and Russia. As of November 2023, the US has the highest number of pipeline products.

Nuclear Imaging Equipment Pipeline Market Analysis by Territories, 2023 (%)

Nuclear Imaging Equipment Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Nuclear Imaging Equipment Pipeline Market

Download a Free Report Sample

Nuclear Imaging Equipment Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the nuclear imaging equipment pipeline market are 510(k), CE, MDL, and NMPA. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Nuclear Imaging Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Nuclear Imaging Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Nuclear Imaging Equipment Pipeline Market

Download a Free Report Sample

Nuclear Imaging Equipment Pipeline Market – Competitive Landscape

Some of the key companies in the nuclear imaging equipment pipeline market are Brain Biosciences Inc, Canon Medical Systems USA Inc, Cubresa Inc, EXINI Diagnostics AB, and FMI Medical Systems Inc among others.

Canon Medical Systems USA Inc: Canon Medical Systems USA Inc (CMSU), a subsidiary of Canon Medical Systems Corp, is a medical equipment manufacturing company. It offers medical imaging systems including angiography, computed tomography, molecular imaging, magnetic resonance imaging, ultrasound, X-ray and digital retinal imaging systems. It also offers EnVision 360, a 3D medical site planning tool and 360° Connect, a customized online platform. CMSU offers services such as cybersecurity protection, service agreements, online parts ordering, installation, training and maintenance and medical finance.

Nuclear Imaging Equipment Pipeline Market Analysis by Companies, 2023

Nuclear Imaging Equipment Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Nuclear Imaging Equipment Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Nuclear Imaging Equipment Pipeline Market Segments Outlook

  • Positron Emission Tomography (PET) Systems
  • Positron Emission Tomography/Computed Tomography (PET/CT) Systems
  • Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems
  • Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems
  • Single Photon Emission Computed Tomography (SPECT) Systems
  • Gamma Camera

Nuclear Imaging Equipment Pipeline Market Territories Outlook

  • The US
  • Europe
  • Canada
  • China
  • Israel
  • Russia

Nuclear Imaging Equipment Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • MDL
  • NMPA

Scope

This report provides:

  • Extensive coverage of the nuclear imaging equipment under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of nuclear imaging equipment and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of nuclear imaging equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Brain Biosciences Inc
Canon Medical Systems USA Inc
Cubresa Inc
ELECTRON Ltd.
Emory University
EXINI Diagnostics AB
FMI Medical Systems Inc
General De Equipment for Medical Imaging SA
General Electric Global Research Center
Jagiellonian University
King's College London
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Molecular Dynamics
MultiFunctional Imaging LLC
Nalu Scientific LLC
Neusoft Medical Systems Co Ltd
Noras MRI products GmbH
Petcoil Inc
Philips Healthcare
Positrigo AG
Positron Corporation
Pulmoscience Inc
QUIBIM SL
Radialis Medical Inc
Ray Vision Intl Corp.
Ruhr-University Bochum
Senotrac Biotechnology LLC
Shanghai United Imaging Healthcare Co Ltd
Shanghai United Imaging Intelligent Medical Technology Co Ltd
Siemens Healthineers AG
Siemens Medical Solutions USA Inc
Stanford University
Symetrica Security Ltd
SynchroPET
Terapet SA
University of Arizona
University of California Davis
University of California Los Angeles
University of California Santa Cruz
University of the Witwatersrand
University of Washington
West Virginia University
Zecotek Photonics Inc
ZumaTek, Inc.

Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures 11

2 Introduction 12

2.1 Nuclear Imaging Equipment Overview 12

3 Products under Development 13

3.1 Nuclear Imaging Equipment – Pipeline Products by Stage of Development 13

3.2 Nuclear Imaging Equipment – Pipeline Products by Segment 14

3.3 Nuclear Imaging Equipment – Pipeline Products by Territory 15

3.4 Nuclear Imaging Equipment – Pipeline Products by Regulatory Path 16

3.5 Nuclear Imaging Equipment – Pipeline Products by Estimated Approval Date 17

3.6 Nuclear Imaging Equipment – Ongoing Clinical Trials 18

4 Nuclear Imaging Equipment – Pipeline Products under Development by Companies 19

4.1 Nuclear Imaging Equipment Companies – Pipeline Products by Stage of Development 19

4.2 Nuclear Imaging Equipment – Pipeline Products by Stage of Development 21

5 Nuclear Imaging Equipment Companies and Product Overview 23

5.1 Brain Biosciences Inc Company Overview 23

5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Canon Medical Systems USA Inc Company Overview 25

5.2.1 Canon Medical Systems USA Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.3 Cubresa Inc Company Overview 26

5.3.1 Cubresa Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 ELECTRON Ltd. Company Overview 27

5.4.1 ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Emory University Company Overview 28

5.5.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 EXINI Diagnostics AB Company Overview 29

5.6.1 EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 FMI Medical Systems Inc Company Overview 30

5.7.1 FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 General De Equipment for Medical Imaging SA Company Overview 33

5.8.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 33

5.9 General Electric Global Research Center Company Overview 35

5.9.1 General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview 35

5.10 Jagiellonian University Company Overview 36

5.10.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 King’s College London Company Overview 37

5.11.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Massachusetts General Hospital Company Overview 38

5.12.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 Memorial Sloan Kettering Cancer Center Company Overview 39

5.13.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Molecular Dynamics Company Overview 40

5.14.1 Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview 40

5.15 MultiFunctional Imaging LLC Company Overview 43

5.15.1 MultiFunctional Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 43

5.16 Nalu Scientific LLC Company Overview 46

5.16.1 Nalu Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 Neusoft Medical Systems Co Ltd Company Overview 47

5.17.1 Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 Noras MRI products GmbH Company Overview 48

5.18.1 Noras MRI products GmbH Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 Petcoil Inc Company Overview 49

5.19.1 Petcoil Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 Philips Healthcare Company Overview 50

5.20.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 50

5.21 Positrigo AG Company Overview 53

5.21.1 Positrigo AG Pipeline Products & Ongoing Clinical Trials Overview 53

5.22 Positron Corporation Company Overview 54

5.22.1 Positron Corporation Pipeline Products & Ongoing Clinical Trials Overview 54

5.23 Pulmoscience Inc Company Overview 55

5.23.1 Pulmoscience Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.24 QUIBIM SL Company Overview 56

5.24.1 QUIBIM SL Pipeline Products & Ongoing Clinical Trials Overview 56

5.25 Radialis Medical Inc Company Overview 57

5.25.1 Radialis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.26 Ray Vision Intl Corp. Company Overview 60

5.26.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 60

5.27 Ruhr-University Bochum Company Overview 61

5.27.1 Ruhr-University Bochum Pipeline Products & Ongoing Clinical Trials Overview 61

5.28 Senotrac Biotechnology LLC Company Overview 62

5.28.1 Senotrac Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.29 Shanghai United Imaging Healthcare Co Ltd Company Overview 63

5.29.1 Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.30 Shanghai United Imaging Intelligent Medical Technology Co Ltd Company Overview 66

5.30.1 Shanghai United Imaging Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.31 Siemens Healthineers AG Company Overview 67

5.31.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 67

5.32 Siemens Medical Solutions USA Inc Company Overview 71

5.32.1 Siemens Medical Solutions USA Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.33 Stanford University Company Overview 72

5.33.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 72

5.34 Symetrica Security Ltd Company Overview 80

5.34.1 Symetrica Security Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.35 SynchroPET Company Overview 81

5.35.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 81

5.36 Terapet SA Company Overview 83

5.36.1 Terapet SA Pipeline Products & Ongoing Clinical Trials Overview 83

5.37 University of Arizona Company Overview 84

5.37.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 84

5.38 University of California Davis Company Overview 85

5.38.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 85

5.39 University of California Los Angeles Company Overview 87

5.39.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 87

5.40 University of California Santa Cruz Company Overview 88

5.40.1 University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview 88

5.41 University of the Witwatersrand Company Overview 89

5.41.1 University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview 89

5.42 University of Washington Company Overview 90

5.42.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 90

5.43 West Virginia University Company Overview 92

5.43.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 92

5.44 Zecotek Photonics Inc Company Overview 93

5.44.1 Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.45 ZumaTek, Inc. Company Overview 94

5.45.1 ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94

6 Nuclear Imaging Equipment- Recent Developments 96

6.1 Nov 23, 2023: Curasight Announces Interim Report January – September 2023 96

6.2 Nov 22, 2023: Oxford Instruments Brings Hill & Smith CFO Hannah Nichols to Board 96

6.3 Nov 22, 2023: Oxford Instruments Names Hill & Smith CFO to Its Board 97

6.4 Nov 22, 2023: Oxford Instruments Announces Appointment of Independent Non-Executive Director 97

6.5 Nov 22, 2023: PET Positivity After Two Cycles of ABVD Is Associated with a Worse Outcome in Localised Hodgkin Lymphoma Although Intensification with BEACOPPesc Is Safe 97

6.6 Nov 20, 2023: Concord Medical Schedules 2023 Annual Meeting of Shareholders 98

6.7 Nov 14, 2023: Oxford Instruments Reports Interim Results for the Six Months to 30 September 2023 98

6.8 Nov 09, 2023: Hyperfine Reports Third Quarter 2023 Financial Results 99

6.9 Nov 08, 2023: Synlab Announces Continued Strong Performance in the Third Quarter of 2023 100

6.10 Nov 08, 2023: Star Equity Holdings Announces 2023 Third Quarter Financial Results 102

6.11 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 105

6.12 Oct 26, 2023: Shanghai United Imaging Healthcare Receives Additional 510(K) Clearance For uMI Panorama 106

6.13 Oct 24, 2023: Cinven Acquires Majority Stake in Synlab AG 106

6.14 Oct 19, 2023: Hyperfine to Announce Third Quarter Financial Results on November 9, 2023 106

6.15 Oct 16, 2023: Bracco Diagnostics Showcases Innovation and Collaborative Vision at RSNA 2023 Annual Meeting 107

6.16 Oct 11, 2023: General De Equipment for Medical Imaging Receives 510(K) Clearance For CareMiBrain 108

6.17 Oct 07, 2023: UK Launches Its First National Total-Body PET Platform for Drug Discovery 108

6.18 Oct 04, 2023: Positron Corporation Announces Attrius PET System Sale 110

6.19 Oct 02, 2023: Oxford Instruments Welcomes New Chief Executive, Richard Tyson 111

6.20 Sep 28, 2023: Canon Medical Systems Obtains Additional 510(k) Clearance for Cartesion Prime 111

6.21 Sep 22, 2023: Concord Medical Reports Financial Results for the First Half of 2023 112

6.22 Sep 21, 2023: United Imaging Healthcare debuts Next-Generation PET/CT Systems, the uMI Panorama Family, and the Integrated Molecular Technology Platform at EANM 114

6.23 Sep 12, 2023: Kromek Detectors in New Spectrum Dynamics Scanner 115

6.24 Sep 11, 2023: Positron and Ochsner Clinic to initiate study of imaging device 116

6.25 Sep 07, 2023: United Imaging Confirms Installation of Country’s First uMI Panorama at Huntsman Cancer Institute 117

6.26 Sep 07, 2023: AURA 10 FDA approved 117

6.27 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation 117

6.28 Sep 05, 2023: Siemens Healthineers Expands Production Site in Rudolstadt, Germany and Creates New Jobs 118

6.29 Aug 24, 2023: Curasight Announces Interim Report January – June 2023 118

6.30 Aug 23, 2023: Xeos Receives 510(k) Clearance for Aura 10 PET/CT Specimen Imager 119

6.31 Aug 14, 2023: Shanghai United Imaging Healthcare Receives Additional 510(k) Clearance for uMI Panorama 120

6.32 Aug 14, 2023: Hyperfine Reports Second Quarter 2023 Financial Results 120

6.33 Jul 31, 2023: Positron Orders Six Attrius PET Systems and Components from Neusoft Positron Medical Systems 121

6.34 Jul 28, 2023: CoxHealth and Philips partner on virtual care solution 121

6.35 Jul 24, 2023: Siemens Medical Solutions Receives FDA 510(K) Clearance for Biograph Vision.X Edge 122

6.36 Jul 24, 2023: Siemens Medical Solutions Receives FDA 510(K) Clearance for Biograph Vision.X 122

6.37 Jun 27, 2023: Genomics- and Image-Guided Subtyping Refines Characterization of Alzheimer’s Disease 122

6.38 Jun 25, 2023: United Imaging Introduces Next-Generation Pet/CT Systems and Integrated Molecular Technology Platform at SNMMI 123

6.39 Jun 25, 2023: SNMMI and IAC Collaborate on New Radiopharmaceutical Therapy Accreditation Program 124

6.40 Jun 13, 2023: Oxford Instruments Announcement of unaudited full-year results for the 12 months to 31 March 2023 125

6.41 Jun 13, 2023: Oxford Instruments Announces Preliminary Results for the 12 Months to 31 March 2023 126

6.42 May 30, 2023: Siemens Healthineers receives 510(k) clearance for Symbia Pro.Specta 127

6.43 May 17, 2023: United Imaging unveils a full portfolio of products at CMEF 2023, Highlighting Its AI Capabilities across Modalities 127

6.44 May 15, 2023: Star Equity Holdings announces 2023 first quarter financial results 128

6.45 May 12, 2023: GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress 130

6.46 May 11, 2023: Hyperfine reports first quarter 2023 financial results 131

6.47 May 10, 2023: SYNLAB reports strong start to fiscal year 2023 132

6.48 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer 134

6.49 May 07, 2023: Spectrum Dynamics receives 510(k) clearance for VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364) 134

6.50 May 07, 2023: Spectrum Dynamics receives 510(k) clearance for VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464) 134

6.51 Apr 28, 2023: Siemens to announce second quarter results FY 2023 135

6.52 Apr 20, 2023: Hyperfine to announce first quarter financial results on May 11, 2023 135

6.53 Apr 19, 2023: Concord Medical Files 2022 Annual Report on Form 20-F 135

6.54 Apr 13, 2023: Ian Barkshire to retire and Richard Tyson to be appointed as Chief Executive Officer of Oxford Instruments 135

6.55 Apr 06, 2023: TTG Imaging Solutions announces first U.S. MiE ANCORIS installation 136

6.56 Mar 21, 2023: Hyperfine Reports Fourth Quarter and Full Year 2022 Financial Results 137

6.57 Mar 15, 2023: Curasight Notice of Annual General Meeting 2023 138

6.58 Mar 15, 2023: SYNLAB Announces Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO 140

6.59 Mar 06, 2023: Hyperfine to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023 141

6.60 Mar 01, 2023: Positron Corporation enters into agreement with Ochsner Clinic Foundation for clinical study of its New “Affinity PET-CT 4D” Device 141

6.61 Feb 15, 2023: GE HealthCare recalls nuclear medicine 600/800 series systems for risk of detector fall that may injure patients 141

6.62 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations 142

6.63 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023 142

6.64 Feb 08, 2023: Hyperfine Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer 143

6.65 Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023 144

6.66 Feb 01, 2023: Canon posts record revenues in medical business unit 146

6.67 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability 146

6.68 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 146

6.69 Jan 23, 2023: The Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital selects Cubresa’s BrainPET Insert System to support brain research studies 149

6.70 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 150

6.71 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 150

6.72 Jan 03, 2023: Siemens Healthineers receives an additional 510(k) clearance for Biograph Vision Quadra PET/CT System 151

6.73 Dec 20, 2022: Positron announces plans for clinical study of its new “Affinity PET-CT 4D” nuclear imaging device 151

6.74 Dec 06, 2022: Associated Medical Professionals of NY Adds Robert Creaven as Chief Operating Officer 152

7 Appendix 153

7.1 Methodology 153

7.2 About GlobalData 156

7.3 Contact Us 156

7.4 Disclaimer 156

Table

Nuclear Imaging Equipment – Pipeline Products by Stage of Development 13

Nuclear Imaging Equipment – Pipeline Products by Segment 14

Nuclear Imaging Equipment – Pipeline Products by Territory 15

Nuclear Imaging Equipment – Pipeline Products by Regulatory Path 16

Nuclear Imaging Equipment – Pipeline Products by Estimated Approval Date 17

Nuclear Imaging Equipment – Ongoing Clinical Trials 18

Nuclear Imaging Equipment Companies – Pipeline Products by Stage of Development 19

Nuclear Imaging Equipment – Pipeline Products by Stage of Development 21

Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 23

CerePET – Product Status 23

CerePET – Product Description 23

FREEMotion – Product Status 24

FREEMotion – Product Description 24

Canon Medical Systems USA Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Next Generation PET Detector – Product Status 25

Next Generation PET Detector – Product Description 25

Cubresa Inc Pipeline Products & Ongoing Clinical Trials Overview 26

BrainPET – Product Status 26

BrainPET – Product Description 26

ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27

Complex Isotope Diagnostics Device – Product Status 27

Complex Isotope Diagnostics Device – Product Description 27

Emory University Pipeline Products & Ongoing Clinical Trials Overview 28

PET/CT Total Body Scan – Product Status 28

PET/CT Total Body Scan – Product Description 28

EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 29

EXINI PET – Product Status 29

EXINI PET – Product Description 29

FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 30

ScintiStar Neuro 100 PET/CT/SPECT – Product Status 30

ScintiStar Neuro 100 PET/CT/SPECT – Product Description 31

ScintiStar Neuro 200 PET/CT/SPECT – Product Status 31

ScintiStar Neuro 200 PET/CT/SPECT – Product Description 32

General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 33

CareMiBrain – Product Status 33

CareMiBrain – Product Description 33

PET System – Brain – Product Status 34

PET System – Brain – Product Description 34

Sentinella New Version – Product Status 34

Sentinella New Version – Product Description 34

General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview 35

Smart Cardiac CT Scanner – Product Status 35

Smart Cardiac CT Scanner – Product Description 35

Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 36

Jagiellonian-PET TOMOGRAPHY – Product Status 36

Jagiellonian-PET TOMOGRAPHY – Product Description 36

King’s College London Pipeline Products & Ongoing Clinical Trials Overview 37

18F-Labelled Molecular Probe – Product Status 37

18F-Labelled Molecular Probe – Product Description 37

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 38

SPECT System – Product Status 38

SPECT System – Product Description 38

Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 39

Micro-NMR System – Product Status 39

Micro-NMR System – Product Description 39

Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview 40

Valiance X12 – Product Status 40

Valiance X12 – Product Description 40

Molecular Dynamics – Ongoing Clinical Trials Overview 41

Valiance X12 – Molecular Dynamics’ Innovative Whole-body CZT Digital SPECT/CT Trial 42

MultiFunctional Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 43

Dual-Tracer PET Device – Product Status 43

Dual-Tracer PET Device – Product Description 43

MultiFunctional Imaging LLC – Ongoing Clinical Trials Overview 44

Dual-Tracer PET Device – Dual-Tracer Theranostic PET 45

Nalu Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview 46

SyMPET – Product Status 46

SyMPET – Product Description 46

Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

NeuWise PET/CT – Product Status 47

NeuWise PET/CT – Product Description 47

Noras MRI products GmbH Pipeline Products & Ongoing Clinical Trials Overview 48

PET-RF Insert – Product Status 48

PET-RF Insert – Product Description 48

Petcoil Inc Pipeline Products & Ongoing Clinical Trials Overview 49

PETcoil System – Product Status 49

PETcoil System – Product Description 49

Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 50

Additional PET Scan – Product Status 50

Additional PET Scan – Product Description 50

AFOV PET Scanner – Product Status 51

AFOV PET Scanner – Product Description 51

PET/CT Scanner – Myocardial Perfusion Assessment – Product Status 51

PET/CT Scanner – Myocardial Perfusion Assessment – Product Description 52

Positrigo AG Pipeline Products & Ongoing Clinical Trials Overview 53

NeuroLF – Product Status 53

NeuroLF – Product Description 53

Positron Corporation Pipeline Products & Ongoing Clinical Trials Overview 54

Affinity PET-CT 4D – Product Status 54

Affinity PET-CT 4D – Product Description 54

Pulmoscience Inc Pipeline Products & Ongoing Clinical Trials Overview 55

PulmoBind – Product Status 55

PulmoBind – Product Description 55

QUIBIM SL Pipeline Products & Ongoing Clinical Trials Overview 56

Total-Body PET/CT Scanner – Product Status 56

Total-Body PET/CT Scanner – Product Description 56

Radialis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Radialis PET Camera – Product Status 57

Radialis PET Camera – Product Description 57

Radialis Medical Inc – Ongoing Clinical Trials Overview 58

Radialis PET Camera – A Pilot Study to Evaluate Low-Dose Positron Emission Mammography Imaging in Visualization and Characterization of Suspicious Breast Abnormalities 59

Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 60

Helmet – PET System – Product Status 60

Helmet – PET System – Product Description 60

Ruhr-University Bochum Pipeline Products & Ongoing Clinical Trials Overview 61

Precision Oncology Tool – Product Status 61

Precision Oncology Tool – Product Description 61

Senotrac Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview 62

Brain Senescence Detection PET Probe – Product Status 62

Brain Senescence Detection PET Probe – Product Description 62

Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Neuro PET/CT – Product Status 63

Neuro PET/CT – Product Description 63

NeuroeXplorer – Product Status 64

NeuroeXplorer – Product Description 64

uPET-MR – Product Status 64

uPET-MR – Product Description 65

Shanghai United Imaging Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

uMI Panorama GS – Product Status 66

uMI Panorama GS – Product Description 66

Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 67

Biograph mMR With Syngo MR E11 – Product Status 67

Biograph mMR With Syngo MR E11 – Product Description 68

Biograph Vision PET/CT System With QualityGuard – Product Status 68

Biograph Vision PET/CT System With QualityGuard – Product Description 68

xSPECT – Product Status 69

xSPECT – Product Description 69

xSPECT Bone – Product Status 69

xSPECT Bone – Product Description 70

xSPECT Quantification – Product Status 70

xSPECT Quantification – Product Description 70

Siemens Medical Solutions USA Inc Pipeline Products & Ongoing Clinical Trials Overview 71

Biograph Vision.X – Product Status 71

Biograph Vision.X – Product Description 71

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 72

Brain-Dedicated PET System – Product Status 72

Brain-Dedicated PET System – Product Description 72

Breast-Dedicated PET System – Product Status 73

Breast-Dedicated PET System – Product Description 73

Dual Panel PET Scanner – Product Status 73

Dual Panel PET Scanner – Product Description 74

Dual-isotope Positron Emitting Tomography System – Product Status 74

Dual-isotope Positron Emitting Tomography System – Product Description 74

Next Generation TOF-PET System – Product Status 75

Next Generation TOF-PET System – Product Description 75

PET Sensitivity Enhancing System – Product Status 75

PET Sensitivity Enhancing System – Product Description 76

PET System – Product Status 76

PET System – Product Description 76

Stanford University – Ongoing Clinical Trials Overview 77

Breast-Dedicated PET System – Pilot Study of a Breast-dedicated PET Camera with 1 Millimeter Spatial Resolution 78

Brain-Dedicated PET System – Pilot Study for Simultaneous PET-MR Imaging of Covid-19 Associated Neurological Complications Using a Brain Dedicated PET Insert 79

Symetrica Security Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

High Resolution Gamma Camera – Product Status 80

High Resolution Gamma Camera – Product Description 80

SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 81

Arterial PET Scanner – Product Status 81

Arterial PET Scanner – Product Description 81

Breast PET-MRI – Product Status 82

Breast PET-MRI – Product Description 82

Terapet SA Pipeline Products & Ongoing Clinical Trials Overview 83

Nuclear Imaging Device – Product Status 83

Nuclear Imaging Device – Product Description 83

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 84

SPECT Imaging Tool – Product Status 84

SPECT Imaging Tool – Product Description 84

University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 85

Anti-aVß6 Diabodies – Product Status 85

Anti-aVß6 Diabodies – Product Description 85

Excised Tissue Imager Device – Product Status 86

Excised Tissue Imager Device – Product Description 86

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 87

PSMA PET/CT Imaging Device – Product Status 87

PSMA PET/CT Imaging Device – Product Description 87

University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview 88

Head And Neck PET System – Product Status 88

Head And Neck PET System – Product Description 88

University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview 89

Coded Aperture Mask – Product Status 89

Coded Aperture Mask – Product Description 89

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 90

DS-PS3 Positron Emission Tomography Detector – Product Status 90

DS-PS3 Positron Emission Tomography Detector – Product Description 90

High Resolution PET Detector – Product Status 91

High Resolution PET Detector – Product Description 91

West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 92

PEM/PET-Breast Imager – Product Status 92

PEM/PET-Breast Imager – Product Description 92

Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 93

New-Generation PET/MRI Scanning Device – Product Status 93

New-Generation PET/MRI Scanning Device – Product Description 93

ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94

PET-CT Scanner – Product Status 94

PET-CT Scanner – Product Description 94

SPECT-CT Scanner – Product Status 95

SPECT-CT Scanner – Product Description 95

Glossary 155

Figures

Nuclear Imaging Equipment – Pipeline Products by Stage of Development 13

Nuclear Imaging Equipment – Pipeline Products by Segment 14

Nuclear Imaging Equipment – Pipeline Products by Territory 15

Nuclear Imaging Equipment – Pipeline Products by Regulatory Path 16

Nuclear Imaging Equipment – Pipeline Products by Estimated Approval Date 17

Nuclear Imaging Equipment – Ongoing Clinical Trials 18

Frequently asked questions

Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.